Glipizide
Product Images NDC 66116-427

2 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 66116-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (6a957e2e F1ea 416b 81de F273234e6db9 01)

Chemical Structure (6a957e2e F1ea 416b 81de F273234e6db9 01)
Chemical structure of Glipizide, showing its molecular framework with various rings and functional groups including sulfonylurea and pyridine moieties.*
FDA Label Image

Glipizide 10mg Tablet (6a957e2e F1ea 416b 81de F273234e6db9 02)

Glipizide 10mg Tablet (6a957e2e F1ea 416b 81de F273234e6db9 02)
Label for Glipizide Tablets USP 10 mg by MedVantx, Inc., containing 60 tablets. Instructions note dosage details on the package insert. The label includes storage information at 20°-25°C and states Rx Only. It features contact information for Teva Pharmaceuticals USA and manufacturing information from Ivax Pharmaceuticals Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.